Inventor
DUDEK HENRYK T
US52 patents
⚠️ This page may combine multiple inventors who share the name “DUDEK HENRYK T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DICERNA PHARMACEUTICALS INC
49 patentsUS10370655B2Aug 6, 2019
Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
DICERNA PHARMACEUTICALS INC14 citations94
US9701966B2Jul 11, 2017
Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
DICERNA PHARMACEUTICALS INC12 citations92
US9458457B2Oct 4, 2016
Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
DICERNA PHARMACEUTICALS INC19 citations92
US8815825B2Aug 26, 2014
Methods and compositions for the specific inhibition of beta-catenin by double-stranded RNA
DICERNA PHARMACEUTICALS INC12 citations92
US10435692B2Oct 8, 2019
Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
DICERNA PHARMACEUTICALS INC3 citations84
US10150965B2Dec 11, 2018
Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA
DICERNA PHARMACEUTICALS INC6 citations84
US10036017B2Jul 31, 2018
Methods and compositions for the specific inhibition of complement component 5(C5) by double-stranded RNA
DICERNA PHARMACEUTICALS INC5 citations84
US9828606B2Nov 28, 2017
Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
DICERNA PHARMACEUTICALS INC7 citations84
US9732347B2Aug 15, 2017
Methods and compositions for the specific inhibition of androgen receptor by double-stranded RNA
DICERNA PHARMACEUTICALS INC6 citations84
US8927515B2Jan 6, 2015
Methods and compositions for the specific inhibition of androgen receptor by double-stranded RNA
DICERNA PHARMACEUTICALS INC9 citations84
US10351854B2Jul 16, 2019
Therapeutic inhibition of lactate dehydrogenase and agents therefor
DICERNA PHARMACEUTICALS INC9 citations83
US11773390B2Oct 3, 2023
Methods and compositions for the specific inhibition of Complement Component 5(C5) by double-stranded RNA
DICERNA PHARMACEUTICALS INC1 citations73
US11060093B2Jul 13, 2021
Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
DICERNA PHARMACEUTICALS INC2 citations73
US10954517B2Mar 23, 2021
Methods and compositions for the specific inhibition of complement component 5(C5) by double-stranded RNA
DICERNA PHARMACEUTICALS INC2 citations73
US10689647B2Jun 23, 2020
Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA
DICERNA PHARMACEUTICALS INC2 citations73
US10676742B2Jun 9, 2020
Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA
DICERNA PHARMACEUTICALS INC3 citations73
US10612023B2Apr 7, 2020
Methods and compositions for the specific inhibition of β-catenin by double-stranded RNA
DICERNA PHARMACEUTICALS INC1 citations73
US10487330B2Nov 26, 2019
Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
DICERNA PHARMACEUTICALS INC2 citations73
US10465195B2Nov 5, 2019
Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
DICERNA PHARMACEUTICALS INC2 citations73
US9562228B2Feb 7, 2017
Methods and compositions for the specific inhibition of MYC by double-stranded RNA
DICERNA PHARMACEUTICALS INC2 citations73
US9243244B2Jan 26, 2016
Methods and compositions for the specific inhibition of beta-catenin by double stranded RNA
DICERNA PHARMACEUTICALS INC3 citations73
US11053502B1Jul 6, 2021
Therapeutic inhibition of lactate dehydrogenase and agents therefor
DICERNA PHARMACEUTICALS INC2 citations72
US10738311B2Aug 11, 2020
Therapeutic inhibition of lactate dehydrogenase and agents therefor
DICERNA PHARMACEUTICALS INC3 citations72
US11661604B2May 30, 2023
Methods and compositions for inhibiting expression of LDHA
DICERNA PHARMACEUTICALS INC3 citations69
US10072263B2Sep 11, 2018
Methods and compositions for the specific inhibition of beta-catenin by double-stranded RNA
DICERNA PHARMACEUTICALS INC1 citations63
US9428752B2Aug 30, 2016
Methods and compositions for the specific inhibition of beta-catenin by double-stranded RNA
DICERNA PHARMACEUTICALS INC2 citations63
US9365850B2Jun 14, 2016
Methods and compositions for the specific inhibition of MYC by double-stranded RNA
DICERNA PHARMACEUTICALS INC2 citations63
US12435336B2Oct 7, 2025
Compositions and methods for inhibiting LPA expression
DICERNA PHARMACEUTICALS INC0 citations62
US12252691B2Mar 18, 2025
Compositions and methods for inhibiting LPA expression
DICERNA PHARMACEUTICALS INC0 citations62
US11912996B2Feb 27, 2024
Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
DICERNA PHARMACEUTICALS INC0 citations62
US11873493B2Jan 16, 2024
Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
DICERNA PHARMACEUTICALS INC0 citations62
US11851658B2Dec 26, 2023
Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
DICERNA PHARMACEUTICALS INC0 citations62
US11697812B2Jul 11, 2023
Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA
DICERNA PHARMACEUTICALS INC0 citations62
US11667918B2Jun 6, 2023
Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA
DICERNA PHARMACEUTICALS INC0 citations62
US11459566B1Oct 4, 2022
Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
DICERNA PHARMACEUTICALS INC0 citations62
US11408002B1Aug 9, 2022
Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
DICERNA PHARMACEUTICALS INC0 citations62
US11359203B2Jun 14, 2022
Therapeutic inhibition of lactate dehydrogenase and agents therefor
DICERNA PHARMACEUTICALS INC0 citations62
US11312961B1Apr 26, 2022
Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
DICERNA PHARMACEUTICALS INC0 citations62
US11312960B1Apr 26, 2022
Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
DICERNA PHARMACEUTICALS INC0 citations62
US11208658B2Dec 28, 2021
Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
DICERNA PHARMACEUTICALS INC0 citations62
US11066672B1Jul 20, 2021
Methods and compositions for the specific inhibition of transthyretin (TTR) by double stranded RNA
DICERNA PHARMACEUTICALS INC0 citations62
US11572562B2Feb 7, 2023
Compositions and methods for inhibiting GYS2 expression
DICERNA PHARMACEUTICALS INC1 citations61
US11566248B2Jan 31, 2023
PCSK9 targeting oligonucleotides for treating hypercholesterolemia and related conditions
DICERNA PHARMACEUTICALS INC1 citations61
US11286488B2Mar 29, 2022
Methods and compositions for inhibiting expression of LDHA
DICERNA PHARMACEUTICALS INC1 citations59
US10844381B2Nov 24, 2020
Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
DICERNA PHARMACEUTICALS INC0 citations52
US10011834B2Jul 3, 2018
Methods and compositions for the specific inhibition of HIF-1α by double-stranded RNA
DICERNA PHARMACEUTICALS INC0 citations52
US9850486B2Dec 26, 2017
Methods and compositions for the specific inhibition of CKAP5 by double-stranded RNA
DICERNA PHARMACEUTICALS INC0 citations52
US9708605B2Jul 18, 2017
Methods and compositions for the specific inhibition of MCL1 by double-stranded RNA
DICERNA PHARMACEUTICALS INC1 citations52
US9670488B2Jun 6, 2017
Methods and compositions for the specific inhibition of met by double stranded RNA
DICERNA PHARMACEUTICALS INC0 citations52
NOVO NORDISK AS
1 patentShowing the top 50 of 52 patents by PatentIndex Score.